Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals

Cardiovasc Drugs Ther. 1990 Aug:4 Suppl 5:905-8. doi: 10.1007/BF02018290.

Abstract

The acute effects of slow-release nifedipine and isosorbide dinitrate on exercise tolerance were compared in nine patients with isolated total coronary artery occlusion showing retrograde filling via collaterals. All patients had a reproducible positive exercise stress test off medication before the study. Each patient was randomized to 10 mg slow-release nifedipine and 5 mg isosorbide dinitrate in a single-blind, cross-over study. The exercise stress test was performed 30 minutes after drug administration. After nifedipine, three patients had a negative exercise stress test, whereas the test was negative after isosorbide dinitrate only in one patient. A significantly higher exercise tolerance was detected at peak exercise after nifedipine than after isosorbide dinitrate, as shown by a longer exercise time (380 +/- 44 vs. 295 +/- 41 seconds, p less than 0.001), a more increased maximum work load (355 +/- 89 vs. 255 +/- 55 W x min, p less than 0.02), and a higher rate-pressure product (30,300 +/- 2,500 vs. 26,100 +/- 2,700, p less than 0.01). In conclusion, these results seem to suggest that nifedipine may have a vasomotor effect on collaterals, since it elevated the threshold of ischemia more than isosorbide dinitrate did in patients with isolated coronary artery occlusion, showing retrograde filling via collaterals.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Angina Pectoris / drug therapy
  • Angiography
  • Arterial Occlusive Diseases / drug therapy*
  • Collateral Circulation / drug effects
  • Collateral Circulation / physiology*
  • Coronary Disease / drug therapy*
  • Exercise / physiology*
  • Exercise Test
  • Female
  • Humans
  • Isosorbide Dinitrate / pharmacology*
  • Isosorbide Dinitrate / therapeutic use
  • Male
  • Middle Aged
  • Nifedipine / pharmacology*
  • Nifedipine / therapeutic use
  • Reproducibility of Results

Substances

  • Nifedipine
  • Isosorbide Dinitrate